GBA3 and neoplasm: Although no specific disease or metabolic association have been identified for cytosolic β-glucosidase, with ongoing studies, it has been shown that reduced or genetic silencing of GBA3 levels in some cancer types contributes to tumor proliferation by increasing tumor chemotherapeutic resistance [6,7,8,9].